Samsung Biologics: Execution of single sales and supply contract
AI reading
★★★ Bullish · Contract win
Signed pharmaceutical contract manufacturing agreement with European pharmaceutical company
Key figures: 계약금액 3,507.7억·매출대비 7.7%
An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).
Other filings by Samsung Biologics
- 09.10 ★★ [Correction] Execution of Supply Contract
- 08.31 ★★★ Strengthening business competitiveness through acquisition of peptide CDMO company
- 08.28 ★★ Decision on large-scale rights offering and public offering for facility investment and acquisition of securities of other corporations
- 08.28 ★★ [Amended] Material report on the decision to acquire shares and equity securities of other corporations
For information only. Not investment advice.